跳至主要内容
临床试验/JPRN-UMIN000002544
JPRN-UMIN000002544已完成未知

Evaluation of clinical usefulness of proton pump inhibitor after endoscopic mucosal resection or endoscopic submucosal dissection for esophageal cancer: A multicenter prospective randomized controlled trial - PPI after EMR/ESD for esophageal cancer

Kyoto University Graduate School of Medicine0 个研究点目标入组 220 人开始时间: 2009年9月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with active peptic ulcer in stomach or duodenum. 2. Patients with active concomitant cancers. 3. Patients requiring systemic steroids medication. 4. Patients with continuous systemic medication of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). 5. Patients who cannot discontinue anticoagulant drug or antiplatelet drug before endoscopic treatment. 6. Patients with severe mental disease or psychotic manifestation. 7.Patients who have been judged as inappropriate for this study for any reasons by the concerning investigators.

研究者

发起方
Kyoto University Graduate School of Medicine

相似试验